Elysium Health a consumer health company that was co-founded by Dr. Leonard Guarente—the director of the Paul F. Glenn Center for Biology of Aging Research at MIT. Elysium works with scientists and researchers from institutions like Harvard, Yale, and Stanford to translate advances in science and technology into clinically validated health products that work. Additionally, Dr. Guarente himself has conducted significant research into the genetic and molecular causes of aging. (Read How To Be Preventative About Your Health)
Basis is the first supplement created by Elysium Health. Basis is based on more than 25 years of aging research. Basis works to increase and sustain levels of NAD+ in our cells. NAD+ is a coenzyme that is essential to hundreds of cellular functions like circadian rhythms, energy creation, DNA protection, and many others. As we age, our levels of NAD+ decline and those functions break down.
A clinical trial conducted by Elysium Health in 2016 demonstrated that two capsules of Basis taken daily over the course of several weeks increased levels of NAD+ by an average of 40 percent in humans. The results of the study were published in the peer-reviewed scientific journal npj: Aging and Mechanisms of Disease. See Related Link for more information.
Basis is a nut-free, gluten-free, vegan, and vegetarian supplement, allowing you to maintain your diet and avoid any dietary allergies you might have. It is also free of any artificial colors and flavors.
Elysium Health sells Basis through their website: https://www.elysiumhealth.com/basis. Each jar contains 30-days’ worth of the supplement (60 capsules) and are sold as a monthly subscription or individually. The plans that Elysium Health offers can be broken down like this:
A month to month subscription costs $50 per month
A six-month subscription costs $270 total ($45 per month)
A one-year subscription: $480 total ($40 per month)
More information about Elysium Health, the company’s team of scientists, and the science behind Basis can be found on Elysium’s page on Twitter.